Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Infectious Disease

Symptoms, Warning Signs, and Look-Alikes

At a Glance

Talaromycosis can cause persistent fever, swollen lymph nodes, cough, shortness of breath, weight loss, and sometimes crater-like skin bumps, but skin lesions are not required. Severe breathing trouble, confusion, jaundice, bleeding, or reduced urine output requires urgent care.

Because talaromycosis is a systemic (body-wide) infection, its symptoms can appear in many different organs at once. It is often described as a “great mimicker” because its presentation overlaps significantly with other serious conditions like tuberculosis or cancer. Understanding these patterns—and knowing when a symptom becomes an emergency—is critical for your care.

Common Signs and Symptoms

Talaromycosis typically begins as a general feeling of being very ill, often referred to as a systemic febrile illness [1]. In a study of over 1,000 patients, the most frequent symptoms included:

  • Persistent Fever: Seen in over 85% of cases [1].
  • Swollen Lymph Nodes: Known as lymphadenopathy, this occurs in about 72% of patients and is often felt in the neck, armpits, or groin [2].
  • Respiratory Issues: Roughly 60% of people experience a cough or shortness of breath [1].
  • Weight Loss: Unintentional weight loss occurs in about half of all patients [1].

Note: These are population-level tendencies, not reliable rules for your personal diagnosis. Rates vary substantially by HIV status and geographic region.

The Role of Skin Lesions

One of the most famous signs of talaromycosis is a specific type of rash. These are typically small, raised bumps (papules) that have a dimple or “crater” in the center, a feature called central umbilication [3]. They often appear on the face, neck, or trunk.

However, a common misconception is that you must have these spots to have the infection. Skin lesions occur in fewer than half (about 44%) of patients [1]. It is entirely possible to have a severe, disseminated infection without a single mark on your skin [4]. If you do not have a rash, your doctors will need to look for the fungus in other places, such as your blood, bone marrow, or lymph nodes [3].

Medical “Look-Alikes”

Because the symptoms are so broad, talaromycosis is frequently confused with other diseases. Your care team must carefully distinguish it from:

  • Tuberculosis (TB): Both cause fever, weight loss, and lung issues. While some studies show that older age or a productive cough might favor TB on a population level, and rash or bone pain might favor talaromycosis, these patterns cannot reliably distinguish the two in an individual [5].
  • Lymphoma: Cancers of the immune system also cause fevers and enlarged lymph nodes. On imaging like CT scans, the two can look identical [6].
  • Lung Cancer: The fungus can create masses or nodules in the lungs that resemble tumors [7].

Because these conditions can look the same—and can even exist at the same time—doctors often require testing like cultures or a biopsy (taking a small tissue sample) to confirm the presence of the fungus [8].

Red Flags: When to Seek Emergency Care

In some cases, talaromycosis can progress rapidly into life-threatening complications. You should contact emergency services or go to the emergency room immediately if you experience any of the following red flags:

Warning Sign What it May Indicate
Severe or Rapidly Worsening Difficulty Breathing Fluid in the lungs or respiratory failure [9].
New Jaundice (Yellowing of eyes/skin) Potential liver injury or complication from the infection or medications [10].
New Confusion or Inability to Stay Awake Severe systemic illness, medication toxicity, or brain involvement [9].
Vomiting Blood or Black/Tarry Stools Severe gastrointestinal bleeding [11].
Markedly Reduced Urine Output or Very Dark Urine Serious kidney injury, a known risk of intravenous antifungal therapies [10].
Severe Muscle Weakness or Racing/Irregular Heartbeat Dangerous drops in potassium or magnesium caused by antifungal treatments [12].

Reporting New Symptoms After Starting Treatment

If you develop new or worsening symptoms (like a spike in fever, a new cough, or worsening lymph nodes) after starting antifungal medications or HIV antiretroviral therapy (ART), contact your care team promptly. Do not assume it is just a normal reaction or “IRIS” (Immune Reconstitution Inflammatory Syndrome). Worsening symptoms require prompt clinical assessment.

Common questions in this guide

What symptoms are common with talaromycosis?
Common symptoms include persistent fever, swollen lymph nodes, cough or shortness of breath, and unintentional weight loss. Some people develop small raised skin bumps with a central dimple, but a rash is not required for talaromycosis to be present.
Can I have talaromycosis without a skin rash?
Yes. Fewer than half of people with talaromycosis develop the characteristic skin lesions, so their absence does not rule out the infection. Doctors may need to look for the fungus in blood, bone marrow, lymph nodes, or other tissue.
How do doctors tell talaromycosis apart from tuberculosis or lymphoma?
Talaromycosis can cause symptoms and imaging findings that resemble tuberculosis, lymphoma, or lung cancer. Because these conditions may look alike, doctors may use cultures and sometimes a biopsy to confirm whether the fungus is present.
Which talaromycosis symptoms require emergency care?
Seek emergency care for severe or rapidly worsening difficulty breathing, new jaundice, confusion or inability to stay awake, vomiting blood, black or tarry stools, markedly reduced urine, or severe weakness with a racing or irregular heartbeat. These signs can indicate serious organ problems, bleeding, or treatment-related complications.
What should I do if symptoms worsen after treatment starts?
Contact your care team promptly if fever, cough, swollen lymph nodes, or other symptoms worsen after starting antifungal medicine or HIV antiretroviral therapy. Do not assume the change is a normal reaction or immune reconstitution inflammatory syndrome, because infection progression, medication toxicity, or another problem may need assessment.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Talaromycosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my symptoms, how are you ruling out tuberculosis or lymphoma?
  2. 2.I don't have skin lesions; does this change how you are looking for the fungus in my body?
  3. 3.Based on my imaging, are there specific areas like my bones or lymph nodes that need a biopsy?
  4. 4.Are my liver function tests or blood counts showing signs of systemic involvement?
  5. 5.What are the specific signs of respiratory or liver failure I should monitor for at home?

References

References (12)
  1. 1

    Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017.

    Ying RS, Le T, Cai WP, et al.

    HIV medicine 2020; (21(11)):729-738 doi:10.1111/hiv.13024.

    PMID: 33369035
  2. 2

    CT findings of Talaromyces marneffei infection among HIV patients with lymphadenopathy.

    Zhu XL, Tang GX, Liu XY, et al.

    Frontiers in medicine 2022; (9()):930678 doi:10.3389/fmed.2022.930678.

    PMID: 36250101
  3. 3

    Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis.

    Narayanasamy S, Dougherty J, van Doorn HR, Le T

    Mycopathologia 2021; (186(5)):707-715 doi:10.1007/s11046-021-00570-0.

    PMID: 34228343
  4. 4

    Absence of cutaneous involvement in disseminated Talaromyces marneffei infection in an AIDS patient: a case report and literature review.

    Pongpech N, Rotjanapan P

    Infection and drug resistance 2019; (12()):1493-1499 doi:10.2147/IDR.S207819.

    PMID: 31239726
  5. 5

    Early differential diagnosis models of Talaromycosis and Tuberculosis in HIV-negative hosts using clinical data and machine learning.

    Qiu Y, Li ZT, Yang SX, et al.

    Journal of infection and public health 2025; (18(6)):102740 doi:10.1016/j.jiph.2025.102740.

    PMID: 40086140
  6. 6

    Nodular Sclerosing Hodgkin Lymphoma Combined with Disseminated Talaromyces marneffei Infection: A Case Report.

    Yang Z, Zeng W, Qiu Y, et al.

    Infection and drug resistance 2021; (14()):5671-5678 doi:10.2147/IDR.S340192.

    PMID: 34992393
  7. 7

    Non-HIV talaromycosis: Radiological and clinical analysis.

    Li X, Hu W, Wan Q, et al.

    Medicine 2020; (99(10)):e19185 doi:10.1097/MD.0000000000019185.

    PMID: 32150056
  8. 8

    Talaromyces Marneffei Infection in Lung Cancer Patients with Positive AIGAs: A Rare Case Report.

    Lin F, Yang Z, Qiu Y, et al.

    Infection and drug resistance 2021; (14()):5005-5013 doi:10.2147/IDR.S340694.

    PMID: 34866920
  9. 9

    Disseminated talaromycosis in HIV-negative patients with lung cancer: a rare case report and literature review.

    He H, Cai L, Xue X, et al.

    BMC infectious diseases 2025; (25(1)):601 doi:10.1186/s12879-025-10985-5.

    PMID: 40275259
  10. 10

    Successful Rescue Therapy for Talaromycosis Complicated by Severe Acute Hepatorenal Failure with Hepatic Encephalopathy in an HIV/HCV-Coinfected Patient: A Case Report.

    Zou J, Qin XY, Zhang MY, et al.

    Infection and drug resistance 2026; (19()):605910 doi:10.2147/IDR.S605910.

    PMID: 42326054
  11. 11

    Disseminated talaromycosis complicated by recurrent gastrointestinal bleeding and hemorrhagic shock: a case report.

    Cui X, Su F, Ye H, et al.

    BMC infectious diseases 2022; (22(1)):238 doi:10.1186/s12879-022-07230-8.

    PMID: 35264100
  12. 12

    A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis.

    Le T, Kinh NV, Cuc NTK, et al.

    The New England journal of medicine 2017; (376(24)):2329-2340 doi:10.1056/NEJMoa1613306.

    PMID: 28614691

This page is for informational purposes only and does not constitute medical advice. Because talaromycosis can worsen quickly and resemble other illnesses, contact your healthcare team or emergency services about concerning symptoms.